SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-09-000126
Filing Date
2009-02-05
Accepted
2009-02-05 16:00:38
Documents
2
Period of Report
2009-01-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 3555
2 poaozeroff.htm EX-24 6323
  Complete submission text file 0001123292-09-000126.txt   11905
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 303 517 5288
Ozeroff Christopher David (Reporting) CIK: 0001454996 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 09573053